Bone Morphogenetic Protein Market to Grow with a CAGR of 3.32% through 2030

Aging population, minimally invasive surgical trends, and expanding applications are expected to drive the Global Bone Morphogenetic Protein Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Bone Morphogenetic Protein Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Bone Morphogenetic Protein Market stood at USD 710.43 million in 2024 and is anticipated to grow with a CAGR of 3.32% in the forecast period. This can be attributed to technological advancements. Continuous research and development efforts by companies in the healthcare and biotechnology sectors are leading to advancements in BMP products. These innovations aim to make BMPs safer, more effective, and easier to use. New delivery systems and formulations are emerging, providing healthcare professionals with more options and flexibility in their treatments. The biocompatible materials and scaffolds are evolving to enhance BMP delivery and efficacy. Innovative materials are being developed to improve the bioactivity and biodegradability of BMP carriers, making them more effective and safer for patients.

The global orthobiologics market has been significantly affected by the unprecedented health crisis, the COVID-19 outbreak. According to a 2021 update from the National Safety Council (NSC) in the United States, the Consumer Product Safety Commission (CPSC) reported a 24% decrease in emergency department visits for consumer product-related injuries during the first seven months of the COVID-19 pandemic. Sports-related injuries, particularly those associated with track and field, saw the most substantial decline, with hockey, soccer, baseball, football, and basketball experiencing over a 60% reduction from March to September 2020. As a result, the bone morphogenetic protein market was notably impacted by the lockdown measures imposed due to COVID-19. However, with improved screening processes and the easing of restrictions, the market is now showing signs of recovery and is expected to achieve stable growth during the study's forecast period. For instance, in April 2022, an article published in Europe PMC reported the resumption of elective surgeries following a year of maintaining a "non-COVID" hospital status in Nassau County, New York, as the COVID-19 positivity rate dropped to 1.2% on May 1, 2021.

Several key factors contribute to the market's growth. The increasing incidence of sports-related injuries, a rising demand for minimally invasive surgical procedures, and ongoing technological advancements in the field of bone morphogenetic proteins are all significant drivers. The Center for Disease Control and Prevention notes a growing number of individuals participating in sports in both developed and developing nations, leading to an upsurge in sports-related injuries. In 2021, the "Arm Injury Statistics" article reported that six million people in the United States suffer a broken bone each year, with hip fractures becoming the most common type in individuals over the age of 75. Fractures account for 16% of all musculoskeletal injuries in the United States, with more than 40% occurring at home. Consequently, the increasing incidence of bone fractures, especially hip fractures in the aging population, is expected to drive the demand for bone morphogenetic proteins. With the growing number of sports-related injuries, there is an escalating need for these proteins, which aid in bone formation.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Bone Morphogenetic Protein Market”

The Global Bone Morphogenetic Protein Market is segmented into type, application, regional distribution, and company.

Based on application, The spinal fusion segment is anticipated to be the fastest-growing in the market, driven by the increasing use of bone morphogenetic protein (BMP). BMP is a protein renowned for its ability to stimulate bone formation and is widely utilized in spinal fusion procedures. Research has shown that BMP significantly enhances fusion rates compared to conventional bone graft surgery, offering surgeons a notable advantage in achieving better outcomes. Its use eliminates the need for harvesting iliac crest autografts (hip grafts), reducing surgical duration and minimizing complication risks. This results in faster and less painful recovery periods for patients. As spinal surgeries continue to rise, the facilitative role of BMP is accelerating its application in spinal fusion procedures, contributing to the rapid growth of this segment.

Furthermore, the growing incidence of spinal cord injuries is driving increased demand for spinal fusion devices. A study published in the National Library of Medicine in May 2022 reveals that between 250,000 and 500,000 individuals worldwide suffer from spinal cord injuries annually, with the majority of these injuries resulting from preventable causes such as violence and car accidents. In the United States, approximately 17,000 new cases are reported each year, and an estimated 282,000 people live with spinal cord injuries. Men, particularly those aged 16 to 30, are more likely to experience sports-related spinal cord injuries. As a result, the high incidence of spinal cord injuries is expected to fuel the demand for spinal fusion devices in the coming years. Additionally, the growing preference for minimally invasive surgical techniques, known for their numerous advantages, is further driving the expansion of the spinal fusion market. 

Major companies operating in Global Bone Morphogenetic Protein Market are:

• Johnson & Johnson
• Ember Therapeutics Inc
• Integra LifeSciences Holdings Corp
• Medtronic PLC
• Bio-Techne Corp
• Merck KGaA
• Pfizer Inc
• Stryker Corp
• Thermo Fisher Scientific Inc
• Zimmer Biomet Holdings Inc

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The Global Bone Morphogenetic Protein Market is entering a new era marked by personalized medicine, minimally invasive techniques, regenerative medicine integration, and innovative delivery systems. These trends, along with expanding applications, biocompatible materials, and ethical considerations, will shape the future of the BMP market. As research and technological advancements continue to unfold, the BMP market is set to play a pivotal role in the advancement of orthopedic and regenerative medicine. It's an exciting time for both patients and the healthcare industry as a whole”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Bone Morphogenetic Protein Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Recombinant Human Bone Morphogenetic Protein (rhBMP) – 2, Recombinant Human Bone Morphogenetic Protein (rhBMP) -7), By Application (Spinal Fusion, Trauma, Reconstructive Surgery, Oral-maxillofacial), By Region, and By Competition 2020-2030F”, has evaluated the future growth potential of Global Bone Morphogenetic Protein Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Bone Morphogenetic Protein Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]               

Website: www.techsciresearch.com